In a study involving 44 participants aged 20-62, researchers observed after four weeks of daily consumption of the probiotic DE111 at 1 billion CFU a significant decrease in the basal levels of several immune cell populations, including CD3+ T cells, cytotoxic T cells, and NKT cells. Moreover, the probiotic group showed an increased capacity for immune response in cells stimulated by an induced inflammation. The results suggests that DE111 may modulate the immune system through action on both innate (rapid response) and adaptive (slow response) immune cell types.
As consumers look to better understand the various functional ingredients in probiotics and distinguish what elements meet specific needs, how…More
Researchers have found that consumption of Deerland Probiotics & Enzymes’ probiotic strain DE111 can improve occasional constipation and/or diarrhea in…More
Innovation for drinks used to mean new packaging or clever marketing. Now innovation means redesigning the drinks themselves. Beverages are…More